CoreLink Surgical, LLC, Today Announced 510(k) Clearance to Market the M3™ Stand-Alone Anterior Lumbar (ALIF) System
September 11, 2018 ST. LOUIS--(BUSINESS WIRE)--CoreLink Surgical, LLC, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the M3™ Stand-Alone Anterior Lumbar (ALIF) System. Jay Bartling, CEO, said, "M3 is our first stand-alone interbody fusion device to feature 3D printing - I continue to be impressed by the ability of our